Craft

BenevolentAI

Market Valuation

$1 B

2017-05-02

Total Funding

$305 M

Revenue

€7.3 M

FY, 2023

BenevolentAI Summary

Company Summary

Overview
BenevolentAI is a company that develops artificial intelligence and machine learning technologies for drug discovery and life sciences. It provides computational tools, including knowledge graphs and ontologies, for pharmaceutical research. The company serves organizations involved in pharmaceutical and biotechnology research and development.
Type
Private
Status
Active
Founded
2013
HQ
London, GB | view all locations
Website
https://www.benevolent.com/
Cybersecurity rating
Sectors

Key People

  • Olivier Brandicourt

    Olivier Brandicourt, Non-Executive Director

    • Susan Liautaud

      Susan Liautaud, Non-Executive Director

      • Ivan Griffin

        Ivan Griffin, COO and Co-Founder

      • Nigel Shadbolt

        Nigel Shadbolt, Non-Executive Director

        Operating MetricsView all

        Trademarks Pending

        2

        May, 2020

        LocationsView all

        2 locations detected

        • London, England HQ

          United Kingdom

          4-8 Maple St, Bloomsbury

        • Babraham, England

          United Kingdom

          Babraham Hall House

        BenevolentAI Financials

        Summary Financials

        Revenue (H1, 2024)
        €2.8M
        Gross profit (H1, 2024)
        €935.0K
        Net income (H1, 2024)
        (€24.8M)
        Cash (H1, 2024)
        €23.0M
        EBIT (H1, 2024)
        (€32.3M)
        Enterprise value
        $977.0M

        Footer menu